ELRIG's Drug Discovery 2026 is at ExCeL London on October 14 and 15, marking 20 years of the meeting.

We will be there to engage about Hit & Lead Discovery programs and our Assays, Biophysics & Screening capabilities, from SPR-HTS and kinetic characterization through to custom assay development. 

Attending from Proteros:

Jonas Noeske, Project Manager, supporting integrated early drug discovery programs
David Witte, Co-Head, Assays, Biophysics & Screening
Dr. Sadaf Kasraie, VP, Strategic Business Development

Reach out to arrange a meeting.